Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jul 27;62(8):e00574-18.
doi: 10.1128/AAC.00574-18. Print 2018 Aug.

Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis

Navisha Dookie  1 , Kogieleum Naidoo  2   3 , Nesri Padayatchi  2   3
Affiliations
Comment

Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis

Navisha Dookie et al. Antimicrob Agents Chemother. .
No abstract available

Keywords: ethambutol; multidrug resistance; pyrazinamide; whole-genome sequencing.

PubMed Disclaimer

Comment in

Comment on

References

    1. Heyckendorf J, Andres S, Köser CU, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. 2018. What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi- and extensively drug-resistant tuberculosis. Antimicrob Agents Chemother 62:e01550-17. doi:10.1128/AAC.01550-17. - DOI - PMC - PubMed
    1. WHO. 2016. Treatment guidelines for drug-resistant tuberculosis,2016 update WHO, Geneva, Switzerland.
    1. Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC. 2016. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project. Lancet Infect Dis 16:1185–1192. doi:10.1016/S1473-3099(16)30190-6. - DOI - PMC - PubMed
    1. Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Tukvadze N, Little B, Bernheim A, Read TD, Guarner J, Derendorf H, Peloquin CA, Blumberg HM, Vashakidze S. 2017. Lung tissue concentrations of pyrazinamide among patients with drug-resistant pulmonary tuberculosis. Antimicrob Agents Chemother 61:e00226-17. doi:10.1128/AAC.00226-17. - DOI - PMC - PubMed
    1. Fofana MO, Shrestha S, Knight GM, Cohen T, White RG, Cobelens F, Dowdy DW. 2017. A multistrain mathematical model to investigate the role of pyrazinamide in the emergence of extensively drug-resistant tuberculosis. Antimicrob Agents Chemother 61:e00498-16. doi:10.1128/AAC.00498-16. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources